SEC 13F Intelligence

B. Metzler Seel. Sohn & Co. AG / ABBV

B. Metzler Seel. Sohn & Co. AG’s Abbvie Inc Position

Does B. Metzler Seel. Sohn & Co. AG own Abbvie Inc (ABBV)? Yes950.4K shares worth $207M (+1.92% of its 13F portfolio) as of Q1 2026, up from 833.7K shares the prior filed quarter.

Position Value
$207M
Q1 2026
Shares
950.4K
% of Portfolio
+1.92%
Quarters Held
18
currently held

Position History ABBV

Reported value by quarter
Q4 ’21: $37MQ4 ’21Q1 ’22: $57MQ2 ’22: $55MQ3 ’22: $47MQ3 ’22Q4 ’22: $63MQ1 ’23: $52MQ2 ’23: $47MQ2 ’23Q3 ’23: $53MQ4 ’23: $59MQ1 ’24: $83MQ1 ’24Q2 ’24: $84MQ3 ’24: $89MQ4 ’24: $77MQ4 ’24Q1 ’25: $102MQ2 ’25: $87MQ3 ’25: $115MQ3 ’25Q4 ’25: $191MQ1 ’26: $207Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026950.4K$207M+1.92%
Q4 2025833.7K$191M+1.66%
Q3 2025498.6K$115M+1.02%
Q2 2025470.7K$87M+0.84%
Q1 2025484.8K$102M+1.05%
Q4 2024435.5K$77M+0.80%
Q3 2024452.8K$89M+0.89%
Q2 2024490.6K$84M+0.81%
Q1 2024456.7K$83M+0.92%
Q4 2023382.5K$59M+0.76%
Q3 2023353.9K$53M+0.79%
Q2 2023346.4K$47M+0.63%
Q1 2023323.9K$52M+0.80%
Q4 2022387.9K$63M+1.07%
Q3 2022352.3K$47M+0.86%
Q2 2022360.8K$55M+0.91%
Q1 2022351.9K$57M+0.76%
Q4 2021273.1K$37M+0.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See B. Metzler Seel. Sohn & Co. AG’s full portfolio or all institutional holders of ABBV.